LAURA MCDONALD: Open Payments
NPI 1528738267 · LENEXA, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$308 in 2 payments from 2 companies in 2025. Trend: 2023 $369 · 2024 $542 · 2025 $308
Food & beverage: $308
| Company | Payments | Amount |
|---|---|---|
| REVANCE THERAPEUTICS, INC. | 1 | $176 |
| Neurocrine BioSciences, Inc. | 1 | $132 |
Products named: DAXXIFY, INGREZZA.
Industry payments across KS — which companies pay providers there.
